Identification of New Potential Inhibitors of Quorum Sensing through a Specialized Multi-Level Computational Approach.
Fábio G MartinsAndré MeloSérgio F SousaPublished in: Molecules (Basel, Switzerland) (2021)
Biofilms are aggregates of microorganisms anchored to a surface and embedded in a self-produced matrix of extracellular polymeric substances and have been associated with 80% of all bacterial infections in humans. Because bacteria in biofilms are less amenable to antibiotic treatment, biofilms have been associated with developing antibiotic resistance, a problem that urges developing new therapeutic options and approaches. Interfering with quorum-sensing (QS), an important process of cell-to-cell communication by bacteria in biofilms is a promising strategy to inhibit biofilm formation and development. Here we describe and apply an in silico computational protocol for identifying novel potential inhibitors of quorum-sensing, using CviR-the quorum-sensing receptor from Chromobacterium violaceum-as a model target. This in silico approach combines protein-ligand docking (with 7 different docking programs/scoring functions), receptor-based virtual screening, molecular dynamic simulations, and free energy calculations. Particular emphasis was dedicated to optimizing the discrimination ability between active/inactive molecules in virtual screening tests using a target-specific training set. Overall, the optimized protocol was used to evaluate 66,461 molecules, including those on the ZINC/FDA-Approved database and to the Mu.Ta.Lig Virtual Chemotheca. Multiple promising compounds were identified, yielding good prospects for future experimental validation and for drug repurposing towards QS inhibition.
Keyphrases
- candida albicans
- biofilm formation
- molecular dynamics
- molecular dynamics simulations
- protein protein
- single cell
- randomized controlled trial
- molecular docking
- pseudomonas aeruginosa
- cell therapy
- staphylococcus aureus
- current status
- drug delivery
- escherichia coli
- public health
- drinking water
- cancer therapy
- adverse drug
- human health
- cystic fibrosis
- risk assessment
- emergency department
- monte carlo
- drug induced
- combination therapy
- smoking cessation